TW200621794A - Pulmonary administration of an antithrombotic compound - Google Patents
Pulmonary administration of an antithrombotic compoundInfo
- Publication number
- TW200621794A TW200621794A TW094132329A TW94132329A TW200621794A TW 200621794 A TW200621794 A TW 200621794A TW 094132329 A TW094132329 A TW 094132329A TW 94132329 A TW94132329 A TW 94132329A TW 200621794 A TW200621794 A TW 200621794A
- Authority
- TW
- Taiwan
- Prior art keywords
- pulmonary administration
- antithrombotic compound
- compound
- antithrombotic
- thrornbin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04104897 | 2004-10-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200621794A true TW200621794A (en) | 2006-07-01 |
Family
ID=34929670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094132329A TW200621794A (en) | 2004-10-06 | 2005-09-19 | Pulmonary administration of an antithrombotic compound |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20090227528A1 (zh) |
| EP (1) | EP1799229B1 (zh) |
| JP (1) | JP2008515849A (zh) |
| CN (1) | CN101035545A (zh) |
| AR (1) | AR051319A1 (zh) |
| AT (1) | ATE418990T1 (zh) |
| AU (1) | AU2005291307B2 (zh) |
| BR (1) | BRPI0516457A (zh) |
| CA (1) | CA2581051A1 (zh) |
| DE (1) | DE602005012130D1 (zh) |
| DK (1) | DK1799229T3 (zh) |
| ES (1) | ES2318551T3 (zh) |
| HK (1) | HK1102692A1 (zh) |
| IL (1) | IL182008A (zh) |
| MX (1) | MX2007003873A (zh) |
| PE (1) | PE20060968A1 (zh) |
| PL (1) | PL1799229T3 (zh) |
| TW (1) | TW200621794A (zh) |
| WO (1) | WO2006037771A1 (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103145774A (zh) * | 2013-03-21 | 2013-06-12 | 苏州鸿洋医药科技有限公司 | 一种抗凝戊糖及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5980865A (en) * | 1995-08-18 | 1999-11-09 | Baker Norton Pharmaceuticals, Inc. | Method for treating late phase allergic reactions and inflammatory diseases |
| EP1087992B1 (en) * | 1998-06-17 | 2008-08-20 | N.V. Organon | Antithrombotic compounds |
| US7087215B2 (en) * | 1998-12-21 | 2006-08-08 | Generex Pharmaceuticals Incorporated | Methods of administering and enhancing absorption of pharmaceutical agents |
| TWI289566B (en) * | 1999-12-07 | 2007-11-11 | N.V.Organon | Antithrombotic compound |
| CA2423469A1 (en) * | 2000-10-18 | 2002-04-25 | Massachusetts Institute Of Technology | Methods and products related to pulmonary delivery of polysaccharides |
| US20040247628A1 (en) * | 2001-10-24 | 2004-12-09 | Frank-Christophe Lintz | Kit for the preparation of a pharmaceutical composition |
-
2005
- 2005-09-19 TW TW094132329A patent/TW200621794A/zh unknown
- 2005-10-03 WO PCT/EP2005/054973 patent/WO2006037771A1/en active Application Filing
- 2005-10-03 CN CNA2005800339541A patent/CN101035545A/zh active Pending
- 2005-10-03 MX MX2007003873A patent/MX2007003873A/es active IP Right Grant
- 2005-10-03 DK DK05796923T patent/DK1799229T3/da active
- 2005-10-03 AT AT05796923T patent/ATE418990T1/de not_active IP Right Cessation
- 2005-10-03 BR BRPI0516457-5A patent/BRPI0516457A/pt not_active IP Right Cessation
- 2005-10-03 EP EP05796923A patent/EP1799229B1/en not_active Not-in-force
- 2005-10-03 PL PL05796923T patent/PL1799229T3/pl unknown
- 2005-10-03 ES ES05796923T patent/ES2318551T3/es active Active
- 2005-10-03 AU AU2005291307A patent/AU2005291307B2/en not_active Ceased
- 2005-10-03 US US11/664,803 patent/US20090227528A1/en not_active Abandoned
- 2005-10-03 CA CA002581051A patent/CA2581051A1/en not_active Abandoned
- 2005-10-03 DE DE602005012130T patent/DE602005012130D1/de active Active
- 2005-10-03 JP JP2007535150A patent/JP2008515849A/ja active Pending
- 2005-10-04 AR ARP050104187A patent/AR051319A1/es unknown
- 2005-10-04 PE PE2005001170A patent/PE20060968A1/es not_active Application Discontinuation
-
2007
- 2007-03-19 IL IL182008A patent/IL182008A/en not_active IP Right Cessation
- 2007-10-10 HK HK07110932.3A patent/HK1102692A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK1799229T3 (da) | 2009-04-27 |
| HK1102692A1 (en) | 2007-11-30 |
| WO2006037771A1 (en) | 2006-04-13 |
| IL182008A (en) | 2010-12-30 |
| AR051319A1 (es) | 2007-01-03 |
| AU2005291307B2 (en) | 2011-02-10 |
| CA2581051A1 (en) | 2006-04-13 |
| EP1799229A1 (en) | 2007-06-27 |
| PL1799229T3 (pl) | 2009-06-30 |
| CN101035545A (zh) | 2007-09-12 |
| EP1799229B1 (en) | 2008-12-31 |
| AU2005291307A1 (en) | 2006-04-13 |
| US20090227528A1 (en) | 2009-09-10 |
| JP2008515849A (ja) | 2008-05-15 |
| BRPI0516457A (pt) | 2008-09-02 |
| ATE418990T1 (de) | 2009-01-15 |
| DE602005012130D1 (de) | 2009-02-12 |
| PE20060968A1 (es) | 2006-10-11 |
| ES2318551T3 (es) | 2009-05-01 |
| IL182008A0 (en) | 2007-07-24 |
| MX2007003873A (es) | 2007-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201907874T4 (tr) | Düşük sülfat fukanlar kullanarak fibröz yapışmaları ya da inflamatuar hastalıkları inhibe etmeye yönelik farmasötik kompozisyonlar ve yöntemler. | |
| MY148108A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
| TW200602022A (en) | Use of PDE III inhibitor for the reduction of heart size in mammals suffering from heart failure | |
| DE60329001D1 (en) | 8-hydroxychinolinderivate | |
| MY145439A (en) | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders | |
| TW200609227A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| WO2009064388A3 (en) | Inhibitors of human methionine aminopeptidase 1 and methods of treating disorders | |
| WO2008012555A3 (en) | Epitope reduction therapy | |
| SG145693A1 (en) | Amino acid prodrugs | |
| MY151048A (en) | Use of flibanserin for the treatment of post-menopausal sexual desire disorders | |
| WO2008020027A3 (en) | 2,5-dihydroxybenzene compounds for the treatment of skin cancer | |
| TW200602325A (en) | Heterocyclylacetic acids as inhibitors of TAFIa | |
| SG158863A1 (en) | Intravenous formulations of pde-5 inhibitors | |
| ZA200806778B (en) | N-Hydroxyacrylamide compounds | |
| TW200509949A (en) | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents | |
| TW200724146A (en) | Use of LGG in the manufacture of a medicament for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant | |
| TW200635595A (en) | Medicaments for the treatment of prevention of fibrotic diseases | |
| WO2008125800A3 (en) | Mmp activated vascular disrupting agents | |
| TW200621794A (en) | Pulmonary administration of an antithrombotic compound | |
| MX2007007051A (es) | Nuevos derivados de tiofenpirimidiona sustituida como inhibidores de la 17??-hidroxiesteroide deshidrogenasa. | |
| WO2003094968A3 (en) | Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases | |
| TNSN07386A1 (en) | Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (tfpi) | |
| PL1838392T3 (pl) | Leki zawierające selen na śródbłonkowe choroby układu naczyniowego | |
| WO2005097138A3 (en) | Combinations comprising oxcarbazepine to treat affective disorders | |
| UA84566C2 (ru) | Производные тиофенпиримидинонов и их применение в терапии, фармацевтическая композиция на их основе |